-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Poster III

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2017: 6:00 PM-8:00 PM
Bldg A, Lvl 1, Hall A2 (Georgia World Congress Center)

Matthew J Maurer, MS1, Hervé Ghesquières, MD, PhD2*, Brian K Link, MD3, Jean-Philippe Jais, MD, PhD4*, Thomas M Habermann, MD5, Carrie A Thompson, MD6, Corinne Haioun, MD7, Cristine Allmer, BS1*, Patrick B Johnston, MD, PhD5*, Richard Delarue, MD8, Ivana N Micallef, MD6*, Frederic Peyrade, MD9*, David J Inwards, MD5*, Nicolas Ketterer, MD10*, Umar Farooq, MD11, Olivier Fitoussi, MD12*, William R Macon, MD6*, Thierry Jo Molina, MD, PhD13*, Sergei Syrbu, MD14*, Andrew L Feldman, MD15, Susan L Slager, PhD1, George J Weiner, MD14*, Stephen M. Ansell, MD, PhD6, James R. Cerhan, MD, PhD1, Gilles Andre Salles, MD, PhD16, Thomas E Witzig, MD5, Herve Tilly17 and Grzegorz S Nowakowski, MD5

1Department of Health Sciences Research, Mayo Clinic, Rochester, MN
2Hospices Civils de Lyon, Université Claude Bernard, Centre Hospitalier Lyon-Sud, Lyon, France
3University of Iowa Hospitals and Clinics, Iowa City, IA
4Hopital Necker, Department of Biostatistics, Paris, France
5Division of Hematology, Mayo Clinic, Rochester, MN
6Mayo Clinic, Rochester, MN
7CHU Henri Mondor, Creteil, France
8Hematology Department / Hemophilia Center, Necker University Hospital, AP-HP, Paris, France
9Centre Antoine Lacassagne, Nice, France
10Clinique Bois-Cerf, Lausanne, Switzerland
11Division of Hematology, Oncology, Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
12Polyclinique Bordeaux Nord-Aquitaine, Bordeaux, France
13Department of Pathology, Hôpital Necker, Paris, France
14University of Iowa, Iowa City, IA
15Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
16Hematology, Hospices Civils de Lyon - Université de Lyon, Pierre-Bénite, France
17Hematology Department, Centre Henri Becquerel, Rouen, France

Stephen M. Ansell, MD, PhD1, Ian W. Flinn, MD, PhD2, Michael B. Maris, MD3, Owen A. O'Connor, M.D., Ph.D.4, Alexander Lesokhin, MD5, Anjali S. Advani, MD6, Mark D. Minden, MD, PhD7, Mary Beth M. Percival, MD8,9, Lisa DS Johnson, PhD10*, Tina Catalano, MSc10*, Meghan Irwin, BSc, EMBA10*, Penka S. Petrova, PhD10*, Robert A. Uger, PhD10*, Eric L Sievers, MD10 and Robert W. Chen, MD11

1Mayo Clinic, Rochester, MN
2Sarah Cannon Research Institute, Nashville, TN
3Colorado Blood Cancer Institute, Denver, CO
4Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Hematology/Oncology, Cleveland Clinic, Cleveland, OH
7Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9Division of Hematology/Department of Medicine,, University of Washington, Seattle, WA
10Trillium Therapeutics Inc., Mississauga, ON, Canada
11City of Hope, Duarte, CA

Alon Rozental, MD1,2*, Anat Gafter-Gvilli, MD1,3,4*, Liat Vidal-Fisher, MD, MSc1,2*, Pia Raanani5,6 and Ronit Gurion, MD1,3*

1Davidoff Cancer Center, Institute of Hematology, Rabin Medical Center, Petah Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Department of Internal Medicine A, Rabin Medical Center, Petah Tikva, Israel
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
6Rabin Medical Center, Petah Tikva, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Cecilia Carpio, MD1*, Reda Bouabdallah, MD2*, Loic Ysebaert, MD, PhD3*, Juan-Manuel Sancho, MD, PhD4*, Gilles Andre Salles, MD, PhD5, Raul Cordoba, MD, PhD6*, Antonio Pinto, MD7*, Mecide Gharibo, MD8*, Drew W. Rasco, MD9*, Carlos Panizo, MD, PhD10*, Jose A. Lopez-Martin, MD, PhD11*, Armando Santoro, MD12*, Antonio Salar, MD, PhD13*, Silvia Damian, MD14*, Alejandro Martín, MD, PhD15*, Gregor Verhoef, MD, PhD16*, Xin Wei17*, Patrick R. Hagner, PhD18*, Kristen Hege, MD19, Alberto Risueño, PhD20*, Anita K. Gandhi, PhD18, Tonia J. Buchholz, PhD19*, Michael Pourdehnad, MD19 and Vincent Ribrag, MD21

1Hospital Universitario Vall d´Hebron, Barcelona, Spain
2Institut Paoli-Calmettes, Marseille, France
3Centre Hospitalier Universitaire de Toulouse, Toulouse, France
4Hospital Universitari Germans Trias i Pujol, Badalona, Spain
5Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
6Hosp. Fundación Jimenez Díaz, Madrid, Spain
7Istituto Nazionale Tumori, Fondazione Pascale, Napoli, Italy
8The Cancer Institute of New Jersey, New Brunswick, NJ
9South Texas Accelerated Research Therapeutics LLC, San Antonio, TX
10Clínica Universidad de Navarra, Pamplona, Spain
1112 de Octubre University Hospital & Research Institute; GETICA, Madrid, Spain
12Instituto Clinico Humanitas, Milano, Italy
13Hospital del Mar, Barcelona, Spain
14Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
15Hospital Universitario de Salamanca and IBSAL, Salamanca, Spain
16UZ Gasthuisberg Leuven, Leuven, Belgium
17Celgene Corporation, Berkeley Heights, NJ
18Celgene Corporation, Summit, NJ
19Celgene Corporation, San Francisco, CA
20Celgene Institute for Translational Research Europe, Seville, Spain
21Institut Gustave Roussy, Villejuif, France

Wael A Harb, MD1*, Catherine S Diefenbach, MD2,3, Nehal Lakhani, MD, PhD4*, Sarah C Rutherford, MD5, Marshall T Schreeder, MD6*, Stephen M. Ansell, MD, PhD7, Taimur Sher, MD8*, David M Aboulafia, MD9, Jonathon B Cohen, MD, MS10, Darrell Nix, BS, PhD11*, Sean Landrette, PhD11*, Kate Flanders, BS11*, Langdon L Miller, MD11, Henry Lichenstein11* and Jeremy S. Abramson, MD, MMSc12

1Horizon Oncology Center, Lafayette, IN
2Perlmutter Cancer Center, New York University, New York, NY
3NYU Perlmutter Cancer Center, NYU School of Medicine, New York, NY
4Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI
5Weill Cornell Medical College, New York, NY
6Clearview Cancer Institute, Huntsville, AL
7Division of Hematology, Mayo Clinic, Rochester, MN
8Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
9Virginia Mason Medical Center, Seattle, WA
10Emory University, Atlanta, GA
11LAM Therapeutics, Inc, Guilford, CT
12Massachusetts General Hospital Cancer Center, Boston, MA

Andres Forero-Torres, MD1*, Kathryn S. Kolibaba, MD2, Herve Tilly3, Gilles Andre Salles, MD, PhD4, Lijia Wang5*, Calvin Lee5 and Jeffrey P. Sharman, MD6

1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
2Compass Oncology, Vancouver, Canada
3University of Rouen, Centre Henri Becquerel, Rouen, France
4South Lyon Hospital Complex, Lyon, France
5Genentech, Inc., South San Francisco, CA
6Willamette Valley Cancer Institute and Research Center, US Oncology Research, The Woodlands, Texas, Springfield, OR

Elise A. Chong, MD1, J. Joseph Melenhorst, PhD2, Jakub Svoboda, MD3, Sunita Dwivedy Nasta, MD3, Daniel J. Landsburg, MD3, Anthony R. Mato, MD3, Lifeng Tian, PhD2*, Harit Parakandi2*, Simon F Lacey, PhD, BS2, Carl H June, MD2 and Stephen J. Schuster, MD3

1Hospital of the University of Pennsylvania, Philadelphia, PA
2Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
3Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Deborah M. Stephens, DO1, Hongli Li, MS2*, Daniel Persky, MD3, Steven I. Park, MD4*, Nancy L. Bartlett, MD5, Lode J. Swinnen6, Carla Casulo, MD7, Jerome D. Winegarden III, MD8*, Louis S. Constine, MD9, Thomas J. Fitzgerald, MD10*, John P. Leonard, MD11, Brad S. Kahl, MD12, Michael L. Leblanc, PhD2*, Joo Y. Song, MD13, Richard I. Fisher, MD14, Lisa M. Rimsza, MD15, Sonali M. Smith, MD16 and Jonathan W. Friedberg, MD9

1Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT
2SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
3Division of Hematology/Oncology, University of Arizona Cancer Center, Tucson, AZ
4Division of Hematology and Oncology, Levine Cancer Institute/Carolinas HealthCare System; and University of North Carolina, Chapel Hill, Chapel Hill, NC
5Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
6Department of Oncology, Johns Hopkins University, Baltimore, MD
7Division of Hematology/Oncology, James P. Wilmot Cancer Center, Rochester, NY
8Division of Hematology/Oncology, St. Joseph Mercy Hospital Cancer Center/Michigan CRC NCORP, Ann Arbor, MI
9Wilmot Cancer Institute, University of Rochester, Rochester, NY
10Imaging and Radiation Oncology Core (IROC), Lincoln, RI
11Department of Medicine, Weill Cornell Medicine, New York, NY
12Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO
13Department of Pathology, City of Hope Medical Center, Duarte, AR
14Department of Hematology/Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA
15Department of Research, Mayo Clinic - Scottsdale, Scottsdale, AZ
16Section of Hematology/Oncology, University of Chicago, Chicago, IL

Gilles Andre Salles, MD, PhD1, Johannes Duell, MD2*, Eva González-Barca, MD, PhD3*, Wojciech Jurczak, PhD, MD4, Anna Marina Liberati, MD5, Zsolt Nagy, MD, PhD6*, Tomáš Papajik, MD, PhD7*, Gianluca Gaidano, MD, PhD8, Marc Andre, MD9*, Nagesh Kalakonda, MD10*, Martin Dreyling, MD, PhD11, Pier Luigi Zinzani, MD, PhD12, Sumeet Ambarkhane, MD, MBBS13, Johannes Weirather, PhD13*, Maren Dirnberger-Hertweck, PhD13* and Kami J. Maddocks, MD14

1Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Bénite, France
2Medizinische Klinik und Poliklinik II, University Hospital of Würzburg, Würzburg, Germany
3Hospital Duran i Reynals, Institut Català d'Oncologia, IDIBELL, Barcelona, Spain
4Department of Hematology, UJ CM, Krakow, Poland
5Oncology-Hematology, Hospital AO Santa Maria, Terni, Italy
61st Department of Internal Medicine, Semmelweis University, Budapest, Hungary
7Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
8University of Eastern Piedmont, Novara, Italy
9Department of Hematology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
10Department of Haematology, Royal Liverpool University Hospital, Liverpool, United Kingdom
11Department of Medicine III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany
12Institute of Hematology “L. e A. Seràgnoli”, Istituto Di Ematologia, Bologna, Italy
13MorphoSys AG, Planegg, Germany
14Division of Hematology, The Ohio State University, Columbus, OH

G A Amos Burke1*, Thomas G. Gross, MD, PhD2, Marta Pillon3*, Veronique Minard-colin4*, Raphael F Delgado5*, József Zsíros6*, Anne Uyttebroeck7*, Jean Michon8*, Catherine M. Bollard, MD9, Monika Csoka10*, Donald A Barkauskas11*, Keith Wheatley, DPhil12*, Anne Aupérin13* and Catherine Patte4*

1Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom
2Center for Global Health, National Cancer Institute, NIH, Rockville, MD
3University of Padova, Padova, ITA
4Institut Gustave Roussy, Villejuif, France
5Dept. de Pediatría., Sociedad Española de Hematología y Oncología Pediátricas, Valencia, Spain
6Emma Children’s Hospital Academic Medical Center University of Amsterdam, Amsterdam, Netherlands
7Center for Human Genetics, University Hospital Leuven, Leuven, Belgium
8Institute Curie, Paris, France
9Program for Cell Enhancement and Technologies for Innovation, Children's National Medical Center, Washington, DC
102nd Dept. of Pediatrics, Semmelweis University, Budapest, Hungary
11Children's Oncology Group, Monrovia, CA
12Institute of Cancer and Genomic Sciences, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
13Biostatistics and Epidemiology Unit, Institut Gustave Roussy, Villejuif, France

Stephen D. Smith, MD1, Brian G. Till, MD1, Sandra L. Kanan, ARNP1*, Andrew J. Cowan, MD2, Qian Wu, PhD3*, Mazyar Shadman, MD4, Katie Blue1*, Lauren Low, PA-C1*, Andrei R. Shustov, MD5, Ryan D. Cassaday, MD6 and Ajay K. Gopal, MD3

1University of Washington/Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Uw/Fred Hutchinson Cancer Research Center, Seattle, WA
5University of Washington/Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
6University of Washington/Fred Hutchinson Cancer Research Center, UW/FHCRC, Seattle, WA

Pengpeng Xu1*, Muchen Zhang1*, Ying Fang1*, Li Wang1,2*, Shu Cheng1* and Wei-li Zhao1,2

1State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology, Shanghai, China
2Pôle de Recherches Sino-Français en Science du Vivant et Génomique; Laboratory of Molecular Pathology, Shanghai, China

Yoshitoyo Kagami, MD1, Kazuhito Yamamoto, MD, PhD2, Taro Shibata, MSc3*, Kensei Tobinai, MD, PhD4, Yoshitaka Imaizumi, MD, PhD5*, Toshiki Uchida, MD, PhD6*, Kazuyuki Shimada, MD7*, Koichiro Minauchi, MD8*, Noriko Fukuhara, MD, PhD9, Hirofumi Kobayashi, MD, PhD10, Nobuhiko Yamauchi, MD11*, Hideki Tsujimura, MD, PhD12, Akira Hangaishi, MD13*, Ryo Tominaga, MD14*, Youko Suehiro, MD15*, Shinichiro Yoshida, MD, PhD16*, Yoshiko Inoue, MD17*, Sachiko Suzuki, MD18*, Michihide Tokuhira, MD19*, Hirokazu Nagai, MD, PhD20, Shigeru Kusumoto, MD21*, Junya Kuroda, MD, PhD22*, Yoshihiro Yakushijin, MD, PhD23, Yasushi Takamatsu, MD, PhD24*, Yasushi Kubota, MD, PhD25*, Kisato Nosaka, MD26, Satoko Morishima, MD, PhD27*, Shigeo Nakamura, MD, PhD28, Dai Maruyama, MD, PhD29, Tomomitsu Hotta, MD30, Yasuo Morishima, MD, PhD2* and Kunihiro Tsukasaki, MD, PhD11

1Toyota Kosei Hospital, Toyota, JPN
2Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan
3JCOG Data Center/Operations Office, National Cancer Center, Tokyo, Japan
4National Cancer Center Hosp., Tokyo, Japan
5Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
6Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
7Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, JPN
8Department of Hematology, Sapporo Hokuyu Hospital, Sapporo-City, JPN
9Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, JPN
10Department of Hematology, Saitama Cancer Ctr. Hosp., Ina, Saitama, JPN
11Department of Hematology, National Cancer Center East, Kashiwa, Japan
12Division of Hematology-Oncology, Chiba Cancer Center, Chiba, JPN
13Division of Hematology, NTT Medical Center Tokyo, Tokyo, Japan
14Division of Hematology, Hyogo Cancer Center, Akashi, Japan
15Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
16Department of Hematology, National Hospital Organization Nagasaki Medical Center, Ohmura, Japan
17Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
18Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
19Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
20Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, JPN
21Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
22Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan
23First Department of Internal Medicine, Ehime University Hospital, Toon, Japan
24Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Fukuoka, Japan
25Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, Saga, JPN
26Department of Hematology, Kumamoto Univ. School of Medicine, Kumamoto, JPN
27Second Department of Internal Medicine,, University of the Ryukyus Hospital, Okinawa, Japan
28Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan
29Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
30National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Carlo Gambacorti-Passerini, MD1, Sergey Orlov2*, Li Zhang3*, Fadi Braiteh4*, Huiqiang Huang5, Taito Esaki6*, Keizo Horibe7*, Jin-Seok Ahn8*, Joseph T. Beck9*, William Jeffrey Edenfield10*, Yuankai Shi11*, Matthew Taylor12*, Kenji Tamura13*, Brian A. Van Tine14*, Shang-Ju Wu, M.D., Ph.D.15*, Jolanda Paolini16*, Sherry Li17* and Tae Min Kim18*

1University Milano Bicocca, San Gerardo Hospital, Monza, Italy
2Saint Petersburg Medical University, Saint Petersburg, Russian Federation
3State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangdong, China
4Comprehensive Cancer Centers of Nevada, Las Vegas, NV
5Department of Medical Oncology, Zhongshan University, Guangdong, China
6National Kyushu Cancer Center, Fukuoka, Japan
7Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
8Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
9Highlands Oncology Group, Fayetteville, AR
10Cancer Institute of Greenville Health System, Greenville, SC
11Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
12Oregon Health & Science University, Portland, OR
13National Cancer Center Hospital, Tokyo, Japan
14Washington University School of Medicine, St. Louis, MO
15Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
16Pfizer Oncology, Milan, Italy
17Pfizer Oncology, La Jolla, CA
18Seoul National University Hospital, Seoul, Korea, Republic of (South)

Alex F. Herrera, MD1, Manish R Patel, MD2*, John M. Burke, MD3, Ranjana H. Advani, MD4, Bruce D. Cheson, MD5, Jeffrey P. Sharman, MD6, Elicia Penuel7*, Andrew G. Polson, PhD7*, Ning Leng, Ph.D.7*, Chunze Li, PhD7*, Eva Schuth, Ph.D.7*, Anjali Vaze, Ph.D.7*, Divya Samineni, Ph.D.7*, Rebecca Elstrom, MD, MA7 and Catherine S Diefenbach8

1Department of Medicine, City of Hope, Duarte, CA
2Sarah Cannon Research Institute, Nashville, TN
3Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
4Stanford Cancer Institute, Stanford University, Stanford, CA
5Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, DC
6US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR
7Genentech, Inc., South San Francisco, CA
8NYU Langone Medical Center, New York, NY

*signifies non-member of ASH